Alaunos Therapeutics Inc

General ticker "TCRT" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $3.5M

Alaunos Therapeutics Inc does not follow the US Stock Market performance with the rate: -41.4%.

Estimated limits based on current volatility of 4.6%: low 1.88$, high 2.07$

Factors to consider:

  • Current price 65.7% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [5.69$, 24.28$]
  • 2024-12-30 to 2025-12-30 estimated range: [3.25$, 11.73$]

Financial Metrics affecting the TCRT estimates:

  • Negative: Non-GAAP EPS, $ of -18.60 <= 0.10
  • Negative: Operating profit margin, % of -99.99 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -68.93 <= 2.35
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85

Similar symbols

Short-term TCRT quotes

Long-term TCRT plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.40MM $2.92MM $0.01MM
Operating Expenses $77.95MM $38.03MM $34.27MM
Operating Income $-77.55MM $-35.10MM $-34.27MM
Non-Operating Income $-1.20MM $-2.62MM $-0.87MM
Interest Expense $1.18MM $3.15MM $1.92MM
R&D Expense $49.64MM $25.02MM $16.28MM
Income(Loss) $-78.75MM $-37.73MM $-35.14MM
Taxes $0.00MM $-0.13MM $0.00MM
Profit(Loss) $-78.75MM $-37.60MM $-35.14MM
Stockholders Equity $58.06MM $38.55MM $6.31MM
Inventory $0.00MM $13.94MM $0.00MM
Assets $94.86MM $64.94MM $8.26MM
Operating Cash Flow $-61.47MM $-29.23MM $-30.14MM
Capital expenditure $3.32MM $0.22MM $0.20MM
Investing Cash Flow $-3.32MM $-0.19MM $1.35MM
Financing Cash Flow $25.78MM $6.37MM $-18.14MM
Earnings Per Share* $-53.80 $-25.97 $-21.97

* EPS are Split Adjusted, recent splits may be reflected with a delay.